Atypical Alterations of cerebrospinal fluid in Guillain Barré Syndrome: Cases Reports.
DOI:
https://doi.org/10.20453/rnp.v84i1.3939Keywords:
Disociación albuminocitológica, hipoglucorraquia, líquido cefalorraquídeo, pleocitosis, poliradiculopatía aguda axonal, Síndrome de Guillain-BarréAbstract
Guillain-Barré syndrome shows a cyto-albuminologic dissociation in most patients. Pleocytosis or hypoglycorrhachia may defer the diagnosis, a reason for which an infectious etiology must be ruled out. Three cases of Guillain- Barré are described, whose cerebrospinal fluid tests showed limphocytic pleocytosis and persistently elevated protein concentration, while one of the cases also showed hypoglycorrhachia, and the classic cyto-albuminologic dissociation was only demonstrated in subsequent analysis. The neurophysiologic evaluation revealed an axonal disruption in all the patients. The atypical alterations in the context of acute flaccid paralysis warrant a retesting of the cerebrospinal fluid in order to rule out other etiologies, but without postponing the start of treatment.
Downloads
References
Tellería-Díaz A, Calzada-Sierra DJ. Síndrome de Guillain-Barré. Rev Neurol. 2002; 34: 966-976.
Munayco CV, Soto MG, Reyes MF, et al. Epidemiología del síndrome de Guillain-Barré en el Perú. Rev Peru Med Exp Salud Pública. 2019; 36(1):10-6. doi:10.17843/rpmesp.2019.361.3729.
Nishimoto Y, Odaka M, Hirata K, et al. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004; 148: 200-2005.
Fokke C, van-den-Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137(1):33-43.
Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: F. A. Davis; 1991. p.57
Domínguez-Mayoral A, Gutiérrez C, López-Domínguez JM, et al. Agrupación de casos de síndrome de Guillain-Barré atípico: ¿es necesario redefinir los criterios diagnósticos y los protocolos microbiológicos? Rev Neurol. 2017; 64: 407-412.
Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019; 15(11):671-683. doi: 10.1038/s41582-019-0250-9.
Rauschkaa H, Jellingerb K, Lasmannc H, et al. Guillain-Barre syndrome with marked pleocytosis or a significant proportion of proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. Eur J Neurol. 2003; 10: 479-486.
Padidam S, Kraft J, Athar MK. Guillain-Barre, Syndrome with Lymphocytic Pleocytosis of the CSF. Int J Brain Disord Treat. 2015; 1:5.
Izadi S, Karimian M. A case of Guillain-Barre. Syndrome with Significant Lymphocytic Pleocytosis. Int Clin Neurosci J. 2017; 4(2): 77-78.
Chow E, Troy S. The differential diagnosis of hypoglycorrhachia in adult patients. Am J Med Sci. 2014; 348(3): 186–190.
Del-Carpio-Orantes L, Peniche-Moguel K, Sánchez-Díaz J, et al. Grupo de estudio del Síndrome de Guillain Barré en temporada de Arbovirus en Veracruz, México. Síndrome de Guillain-Barré durante el brote de Zika en Veracruz, México, en 2016-2017. Med Int Méx. 2020; 36: 33-9. doi: 10.24245/mim.v36i1.2921
Kemmotsu Y, Nakayama T, Matsuura H, et al. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease. Pediatr Rheumatol Online J. 2011; 9:28. doi: 10.1186/1546-0096-9-28
Bourque PR, Brooks J, Warman-Chardon J, et al. Cerebrospinal fluid total protein in Guillain–Barré syndrome variants: correlations with clinical category, severity, and electrophysiology. J Neurol. 2020; 267(3):746-751. doi: 10.1007/s00415-019- 09634-0
Vidrio-Becerra ME, Valle-Leal J, Loaiza-Sarabia ME, et al. Valor de la concentración de proteínas en el líquido cefalorraquídeo en pacientes pediátricos con síndrome de Guillain-Barré. Med Clin (Barc). 2018; 150 (9): 331-335.
Sahin S, Cinar N, Karsidag S. Are cerebrospinal fluid protein levels and plasma neutrophil/lymphocyte ratio associated with prognosis of Guillain Barré Syndrome? Neurol Int. 2017; 9(2):7032. doi: 10.4081/ ni.2017.7032
Rodríguez-Morales AJ, Failoc-Rojas VE, Díaz-Vélez C. Gastrointestinal, respiratory and/or arboviral infections? What is the cause of the Guillain-Barré syndrome epidemics in Perú? Current status - 2019. Travel Med Infect Dis. 2019;30:114-116. doi: 10.1016/j.tmaid.2019.06.015